middle.news
Vitrafy Breaks Into US Cell and Gene Therapy Market with Charter Medical Deal
9:17am on Wednesday 2nd of September, 2026 AEST
•
Healthcare
Read Story
Vitrafy Breaks Into US Cell and Gene Therapy Market with Charter Medical Deal
9:17am on Wednesday 2nd of September, 2026 AEST
Key Points
First US cell and gene therapy deployment for Vitrafy
Cryopreservation ecosystem installed at Charter Medical's Innovation Hub
Initial six-month term with no immediate revenue
Focus on freeze curve optimisation to improve cell recovery
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE